Methanol POC Study

This study is developing and testing a simple bedside test to diagnose methanol poisoning. The aim is to make diagnosis faster, more accurate, and easier to access, particularly in settings where laboratory facilities are limited.

Methanol poisoning causes thousands of deaths each year, often during outbreaks linked to contaminated alcohol. Early diagnosis is major. With prompt treatment, many deaths and long-term complications can be prevented. In many settings, however, diagnosis is slow and relies on laboratory tests that are not always available.

Methanol itself is not highly toxic, but it is converted in the body into formate. Formate is the substance that causes harm, leading to blindness, brain injury, and death. Detecting formate quickly is therefore essential for early diagnosis.

This study focuses on a point-of-care test that measures formate from a single drop of blood. The test can be used at the bedside and provides results within minutes. It does not require specialist equipment or a laboratory.

If the test performs well, it could improve how methanol poisoning is identified and treated, especially in low-resource healthcare settings.

The research is made up of two linked studies.

• The first study assesses how well the bedside test performs by comparing it with the standard laboratory method. This will show how accurately the test can identify methanol poisoning.
• The second study looks at how the test works in practice. Hospitals will use different diagnostic approaches so researchers can understand whether the bedside test helps clinicians reach a diagnosis more quickly, improves treatment decisions, and reduces unnecessary use of antidotes.

Together, these studies will inform a larger future trial focused on patient outcomes, including survival.

This study focuses on improving care in urgent situations. A rapid bedside test could help clinicians start treatment sooner and avoid unnecessary treatment when methanol poisoning is not present.

The study will also contribute to raising awareness of methanol poisoning, strengthening research capacity, and supporting improvements in diagnosis and care over time.

At its heart, this study is about improving care in urgent, life-threatening situations. A fast, reliable bedside test could help clinicians make decisions sooner - starting treatment when it’s needed and avoiding it when it’s not.

Beyond the immediate clinical impact, the project also aims to raise awareness of methanol poisoning as a global health issue, strengthen research capacity in participating countries, and support better systems for diagnosis and treatment in the future.